Valeritas (VLRX) Trading Down 3.4%

Valeritas Holdings Inc (NASDAQ:VLRX)’s share price fell 3.4% during mid-day trading on Monday . The stock traded as low as $0.30 and last traded at $0.31. 753,928 shares were traded during mid-day trading, a decline of 36% from the average session volume of 1,171,298 shares. The stock had previously closed at $0.33.

Several research firms have recently issued reports on VLRX. Zacks Investment Research lowered Valeritas from a “buy” rating to a “hold” rating in a report on Saturday, March 9th. Oppenheimer reissued a “buy” rating on shares of Valeritas in a report on Monday, January 14th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Valeritas currently has a consensus rating of “Buy” and an average price target of $2.10.

The firm has a market cap of $32.31 million, a price-to-earnings ratio of -0.18 and a beta of 2.04. The company has a quick ratio of 3.98, a current ratio of 4.47 and a debt-to-equity ratio of 2.82.

Valeritas (NASDAQ:VLRX) last announced its quarterly earnings data on Tuesday, March 5th. The company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.13) by ($0.07). The business had revenue of $6.89 million during the quarter, compared to analyst estimates of $6.70 million. Equities analysts anticipate that Valeritas Holdings Inc will post -0.56 EPS for the current fiscal year.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC grew its holdings in Valeritas by 138.0% during the fourth quarter. Geode Capital Management LLC now owns 186,971 shares of the company’s stock valued at $60,000 after purchasing an additional 108,416 shares during the period. Millennium Management LLC bought a new position in Valeritas during the fourth quarter valued at $165,000. Weiss Multi Strategy Advisers LLC bought a new position in Valeritas during the fourth quarter valued at $41,000. CVI Holdings LLC bought a new position in Valeritas during the fourth quarter valued at $832,000. Finally, Northern Trust Corp lifted its position in shares of Valeritas by 855.4% during the fourth quarter. Northern Trust Corp now owns 185,469 shares of the company’s stock worth $60,000 after acquiring an additional 166,057 shares in the last quarter. 36.46% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Valeritas (VLRX) Trading Down 3.4%” was published by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at

Valeritas Company Profile (NASDAQ:VLRX)

Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject technology for needle-free injection systems; and Micro-Trans technology for microneedle design, fabrication, and drug delivery.

Further Reading: Treasury Bonds

Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with's FREE daily email newsletter.